By definition, ocular adnexal lymphomas (OALs) arise
|
|
- Caren Sharp
- 5 years ago
- Views:
Transcription
1 A TNM-Based Clinical Staging System of Ocular Adnexal Lymphomas Sarah E. Coupland, MBBS, PhD; Valerie A. White, MD, MHSc; Jack Rootman, MD; Bertil Damato, MD, PhD; Paul T. Finger, MD Context. The ocular adnexal lymphomas (OAL) arise in the conjunctiva, orbit, lacrimal gland, and eyelids. To date, they have been clinically staged using the Ann Arbor staging system, first designed for Hodgkin and later for nodal, non Hodgkin lymphoma. The Ann Arbor system has several shortcomings, particularly when staging extranodal non Hodgkin lymphomas, such as OAL, which show different dissemination patterns from nodal lymphomas. Objective. To describe the first TNM-based clinical staging system for OAL. Design. Retrospective literature review. Results. We have developed, to our knowledge, the first American Joint Committee on Cancer International Union Against Cancer TNM-based staging system for OAL to overcome the limitations of the Ann Arbor system. Our staging system defines disease extent more precisely within the various anatomic compartments of the ocular adnexa and allows for analysis of site-specific factors not addressed previously. It aims to facilitate future studies by identifying clinical and histomorphologic features of prognostic significance. This system is for primary OAL only and is not intended for intraocular lymphomas. Conclusions. Our TNM-based staging system for OAL is a user-friendly, anatomic documentation of disease extent, which creates a common language for multicenter and international collaboration. Data points will be collected with the aim of identifying biomarkers to be incorporated into the staging system. (Arch Pathol Lab Med. 2009;133: ) By definition, ocular adnexal lymphomas (OALs) arise in the conjunctiva, the orbit, the lacrimal gland, or the eyelids. These tumors can be solitary or multicentric, unilateral or bilateral. They can invade bone, sinuses, nasopharynx, and the cranial cavity. Dissemination can occur to ipsilateral and/or contralateral regional lymph nodes as well as to more distant nodes centrally and peripherally (eg, para-aortic and popliteal nodes). Ocular adnexal lymphomas are mostly extranodal non Hodgkin lymphomas (NHLs), with the most common subtype being the extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type, 1 7 according to the latest World Health Organization lymphoma classification. 8 Although rare, T/NK-cell lymphomas also arise in the ocular adnexa. 9,10 As with other extranodal marginal zone B-cell lymphomas, recurrences occur commonly within the ocular adnexa and other extra-nodal sites, such as salivary glands. Treatment is largely based on radiotherapy with or without systemic chemotherapy and/or Accepted for publication April 3, From the Department of Pathology, University of Liverpool, Liverpool, England (Dr Coupland); the Departments of Pathology and Laboratory Medicine (Dr White) and Ophthalmology (Dr Rootman), Vancouver General Hospital, Vancouver, Canada; the St. Paul s Eye Unit, Royal Liverpool University Hospital, Liverpool, England (Dr Damato); and The New York Eye Cancer Center, New York City (Dr Finger). The authors have no relevant financial interest in the products or companies described in this article. Reprints: Sarah E. Coupland, MBBS, PhD, Department of Pathology, School of Cancer Studies, University of Liverpool, Duncan Bldg, Daulby St, Liverpool L69 3GA, England ( s.e.coupland@liverpool. ac.uk). immunotherapy, according to clinical staging and histologic subtyping. The 10-year, disease-specific mortality, which varies according to lymphoma subtype, is approximately 5% to 10%. 5 To date, the most widely used staging system for malignant lymphomas is the Ann Arbor staging system, which was first used for Hodgkin disease in Although its utility for the staging of other lymphomas has been challenged, the modified Ann Arbor system 12 remains the primary means for determining clinical stage of patients with both nodal and extranodal NHL. Ann Arbor staging is essentially an anatomic assessment of disease that also takes into account any systemic symptoms. It divides the disease extent into 4 stages (stages I IV), according to lymph node group involvement above and below the diaphragm and with or without involvement of organs, such as the spleen, liver, and bone marrow. Other staging systems have been developed for extranodal lymphomas at other sites, such as skin and gastric mucosa. In addition, other prognostic indices have been devised, taking into account features such as age, serum lactate dehydrogenase levels, and the general condition of the patient. These systems supplement the Ann Arbor staging classification to enhance treatment planning and patient stratification in clinical trials. MATERIALS AND METHODS The Ann Arbor staging system has a number of shortcomings, particularly when staging extranodal NHLs, such as OALs, which essentially show different dissemination patterns from nodal lymphomas. As with other locations of extranodal lymphoma (eg, gastrointestinal lymphomas), 13 the Ann Arbor stag Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al
2 Figure 1. The cumulative survival rate of patients with ocular adnexal lymphomas (OALs) with stage IE and stage II according to the Ann Arbor staging system. Even in large cohorts, there is a large group of patients within stage IE whose subsequent clinical course is difficult to differentiate from each other. Reprinted from Coupland et al 5 with permission from Springer, ing system is not ideal for documenting the specific, relevant features of primary OAL. The reasons for this include the following: 1. Disproportionate Staging Distribution. Two-thirds of primary OALs present as a localized mass, which, according to the Ann Arbor system, would be categorized and recorded as a stage IE tumor (E, extranodal; Figure 1). 2,4,6,14 17 Consequently, there is a disproportionately high number of patients in stage IE, whose prognosis cannot be consistently distinguished from each other on either clinical or histomorphologic criteria. 2. Anatomic Location. Lymphomas occurring in particular locations within the ocular adnexa are associated with an increased risk of disseminated disease. 18 For example, lymphomas occurring in the eyelid or orbit with lacrimal gland involvement are associated with a worse prognosis. 18,19 Within the subgroup of conjunctival lymphomas, systemic disease is more common in patients with lymphomas located at an extralimbal site (ie, in the fornix or midbulbar region). 20 Furthermore, some evidence suggests that whether the lymphoma is located predominantly in the anterior or posterior orbit is of prognostic significance (J.R., unpublished data, 2008). 21 Lymphomatous involvement of the extraocular muscles has been demonstrated by some to be a poor prognostic factor. 22 Currently, all OALs confined to the ocular adnexa are categorized and recorded by the Ann Arbor system as stage IE, whatever their exact location or size. This system, therefore, does not discriminate between patients with high-risk or low-risk stage IE. 3. Extent of Primary Tumor Infiltration. New imaging techniques enable a more precise definition of tumor extent. 23,24 This feature cannot be documented adequately using the Ann Arbor staging system. 4. Multiple Tumors. Ocular adnexal lymphomas can occur as multiple tumors within the same site, for example, in the conjunctiva. Large studies show that such multiple conjunctival tumors are associated with a worse prognosis. 20 There is no allowance for the staging of multiple tumors in the Ann Arbor classification. 5. Lymph Node Involvement. Recent studies indicate that conjunctival OAL with nodal involvement is associated with a worse prognosis. 25 Currently, the Ann Arbor system categorizes lymph node involvement by OAL as stage II or stage III. This information, however, is vague, and could be made more precise by documenting, first, whether any regional lymph node involvement is ipsilateral or contralateral and, second, whether any distant lymph nodes are affected, as indicated below. 6. Multicentricity and Bilaterality of OAL. Ocular adnexal lymphomas can occur in separate noncontiguous sites in the ocular adnexa (eg, concurrent but noncontiguous conjunctival and orbital tumors). Such multiple tumors can be either ipsilateral or, in up to 15% of cases, bilateral. Presently, both of these would be staged and recorded as IE, using the Ann Arbor staging system. 7. Noncontiguous Involvement of Tissues External to the Ocular Adnexa. Commonly, OALs are associated with concurrent involvement of extranodal sites, such as the parotid and submandibular glands. Such involvement cannot be documented using the Ann Arbor classification system. RESULTS Under the auspices of the American Joint Committee on Cancer, we have developed a staging system to overcome the limitations of the Ann Arbor system. 26 This new system uses the standard tumor, node, and metastasis (TNM) format. It is based on published evidence and the clinical experience of the authors. Our OAL staging system (Table) aims to define disease extent more precisely and to facilitate future studies identifying clinical and histomorphologic features of prognostic significance. This system is not intended for secondary lymphomatous involvement of ocular adnexa or for intraocular lymphomas. It must be emphasized that our OAL staging system should be used in conjunction with histologic subtyping according to the latest World Health Organization lymphoma classification. 8 The T stage defines the lymphomatous involvement of the ocular adnexa. It essentially subdivides the stage IE of the Ann Arbor classification into finer subgroups, allowing for better documentation of disease extent. T1 categorizes conjunctival OALs according to whether they are bulbar (T1a; Figure 2), or nonbulbar (T1b; ie, confined to fornix and/or caruncle). Tumors that involve both bulbar and nonbulbar conjunctiva are placed in the T1c category (Figure 3). These categories are based on evidence indicating that nonbulbar conjunctival involvement carries a worse prognosis. Multifocal tumors are identified using Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al 1263
3 Primary tumor (T) TX Lymphoma extent not specified T0 No evidence of lymphoma T1 T1a T1b T1c T2 T2a T2b T2c T2d T3 T4 T4a T4b T4c T4d TNM Clinical Staging for Ocular Adnexal Lymphomas (OALs) a Lymphoma involving the conjunctiva alone without orbital involvement Bulbar conjunctiva only Palpebral conjunctiva fornix caruncle Bulbar and nonbulbar conjunctival involvement Lymphoma with orbital involvement any conjunctival involvement Anterior orbital involvement, b but no lacrimal gland involvement ( conjunctival disease) Anterior orbital involvement with lacrimal gland involvement ( conjunctival disease) Posterior orbital involvement ( conjunctival involvement any extraocular muscle involvement) Nasolacrimal drainage system involvement ( conjunctival involvement but not including nasopharynx) Lymphoma with preseptal eyelid involvement 23,c orbital involvement any conjunctival involvement Orbital adnexal lymphoma extending beyond orbit to adjacent structures, such as bone and brain Involvement of nasopharynx Osseous involvement (including periosteum) Involvement of maxillofacial, ethmoidal frontal sinuses Intracranial spread Lymph node involvement (N) d NX Involvement of lymph nodes not assessed N0 No evidence of lymph node involvement N1 Involvement of ipsilateral regional lymph nodes d N2 Involvement of contralateral or bilateral regional lymph nodes N3 Involvement of peripheral lymph nodes not draining ocular adnexal region N4 Involvement of central lymph nodes Distant metastasis (M) MX Dissemination of lymphoma not assessed M0 No evidence of involvement of other extranodal sites M1 Lymphomatous involvement in other organs recorded either at first diagnosis or subsequently M1a Noncontiguous involvement of tissues or organs external to the ocular adnexa (eg, parotid glands, submandibular gland, lung, liver, spleen, kidney, breast) M1b Lymphomatous involvement of the bone marrow M1c Both M1a and M1b involvement a Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2009) published by Springer Science and Business Media LLC, b The anterior orbit is defined as the area between the orbital septum and the equator of the globe. The posterior orbit is defined as the area posterior to the equator of the globe, extending to the orbital apex. c Eyelid involvement is said to exist when the OAL infiltrates preseptal tissues (ie, tissues anterior to the orbital septum). d Regional lymph nodes, which include the preauricular (parotid), submandibular, and cervical lymph nodes. the prefix m. Similarly, the prefix b indicates bilateral ocular adnexal disease (Figure 4). These prefixes can be applied to any T stage. Stage T2 defines any OALs involving the orbit, whether or not the conjunctiva is affected. Several studies have shown that the prognosis is worse with orbital involvement than with lymphoma confined to conjunctiva (Figure 4) An orbital tumor is categorized as anterior and posterior, according to its predominant location in relation to the equator of the globe. The anterior orbit is defined as the area between the orbital septum and the equator of the globe. The posterior orbit is defined as the area posterior to the equator of the globe, extending to the orbital apex. This distinction is based on one of the authors unpublished data (J.R., 2008) and will be investigated by outcomes analyses. Without such tentative categorization, future investigations evaluating the prognostic value of T2 subgroups would be more difficult. Ocular adnexal lymphomas infiltrating the nasolacrimal drainage system, but not reaching the nasopharynx, are staged as T2d. Stage T3 indicates OAL infiltration of preseptal eyelid tissues (ie, tissues anterior to the orbital septum, such as dermis, orbicularis muscle, or eyelid skin) as defined previously (Figure 5). 27 There is much evidence showing that preseptal eyelid involvement is associated with a worse prognosis than disease confined to conjunctiva and/or orbit. 3 5,15,18,19,28 Tumors are categorized as T3 irrespective of any such conjunctival and/or orbital involvement. Stage T4 refers to tumor invasion of bony and soft-tissue structures beyond the ocular adnexa, including the periosteum, bone, nasopharynx, the adjacent sinuses, and the intracranial cavity (Figure 6). These advanced stages are usually seen with high-grade lymphomas, which behave aggressively (eg, diffuse large B-cell lymphomas, mantle cell lymphomas, and T/NK cell lymphomas). 9,10,29,30 Lymph node involvement of OAL at diagnosis is documented using the N stage. The regional lymph nodes of the ocular adnexa include the submandibular, preauricular, and cervical lymph nodes. Distant nodes include central nodes, located in the trunk (eg, mediastinal and para-aortic nodes) and peripheral nodes at other distant sites not draining the ocular adnexa (eg, popliteal lymph nodes). The different substages of N indicate whether the lymph node involvement is local (ipsilateral, contralateral, bilateral), central, or peripheral. The M stage documents involvement of an extranodal site distant to the ocular adnexa as well as bone marrow infiltration (Figure 7). The most common metastatic sites of OAL include salivary glands, gastrointestinal tract, lung, and liver. Lymphomatous infiltration of these organs 1264 Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al
4 Figure 2. Bulbar conjunctival ocular adnexal lymphoma (OAL) with a TNM stage of T1a. Figure 3. An ocular adnexal lymphoma (OAL) involving both bulbar and nonbulbar conjunctiva is placed in the T1c category. Figure 4. Magnetic resonance imaging of an ocular adnexal lymphoma (OAL) involving the lacrimal gland and extending into the posterior orbit (pt2c). Figure 5. Clinical picture of an ocular adnexal lymphoma (OAL) involving the eyelid and periocular skin (pt3). Figure 6. Magnetic resonance imaging of an extensive ocular adnexal lymphoma (OAL) with involvement of eyelid, orbit, and periosteal tissues, representing pt4. Figure 7. Bone marrow infiltration of neoplastic lymphocytes arising from the same B-cell clone of a primary ocular adnexal lymphoma (OAL; ptxpnxm2) (hematoxylin-eosin, original magnification 40). Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al 1265
5 can be recorded at either the time of first diagnosis or subsequently, in which case the term M1 is used. Bone marrow infiltration occurs in up to 30% of patients with OAL. 2,4 This infiltration can occur in different patterns (eg, micronodular, paratrabecular, or diffuse interstitial) and should be documented as M2. COMMENT This is the first TNM staging system for OAL. 26 It describes such tumors more precisely than the Ann Arbor system. The stages we have defined are based on published evidence, much of which has been corroborated by multiple, independent studies, some with large patient numbers. 2 5,15 19,31 35 The T2a and T2b stages, documenting the extent of orbital involvement, are not based on published evidence, but rather, on extensive experience, but should facilitate future evaluation of these categories. Intuitively, one would expect that more extensive orbital involvement would reflect more aggressive or more advanced disease and, hence, a worse prognosis. A weakness of our staging system is that it has not been validated on a large cohort of patients; however, such studies both retrospective and prospective are in progress. Encouragingly, our proposed TNM staging system for OAL has been ratified by both the International Union against Cancer and the College of American Pathologists (K. T. Bradley, D. A. Arber, M. Brown, et al, unpublished data, 2008). It must be emphasized that this proposed staging system is for primary OAL only and is not intended for intraocular lymphomas. It is acknowledged that controversy does exist about some patients with extensive systemic disease as to whether the lymphoma manifestation in the ocular adnexa is primary or secondary. Careful analysis of the clinical history and ascertaining the presence or absence of any previous evidence of lymphomatous disease elsewhere usually enables clarity in such cases. Future plans include the incorporation of nonclinical data with the aim of identifying biomarkers of prognostic relevance. Such data might include histomorphologic lymphoma subtyping, immunohistochemical indicators of cell proliferation (eg, Ki-67), as well as cytogenetic and molecular genetic information. 40,41 Clinical data, such as age, general condition, and serum markers (eg, lactate dehydrogenase level) will be merged with our TNM scores to derive prognostic indices, providing more predictive information for the individual patient. CONCLUSIONS Current staging systems for NHL are not useful for the clinical staging of OALs. A user-friendly staging system for OAL would improve communication about the stage of disease, selection of appropriate management, standardization of enrollment and response criteria in clinical trials, and collection/analysis of prospective survival data. The proposed American Joint Committee on Cancer International Union Against Cancer staging system for OAL is the first specialized TNM-based staging system of ocular lymphomas. It allows for analysis of site-specific factors not addressed by previous systems. The TNM OAL staging system is currently an anatomic documentation of disease extent but will, in the future, incorporate additional prognostic information (eg, clinical, biologic, and molecular biologic data). We sincerely thank Stefan Seregard, MD, and James O. Armitage, MD, for their involvement in the design of, and discussions about, the TNM staging system for OAL as well as proofreading the TNM chapter in the 7th edition of the AJCC s Cancer Staging Handbook (in press). References 1. White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology. 1995;102(12): Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology. 1998;105(8): Jakobiec FA, Knowles DM. An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc. 1989;87: discussion Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000;84(8): Coupland SE, Hellmich M, Auw-Haedrich C, Lee W, Stein H. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol. 2004;242(2): Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006;108(5): Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008;145(6): Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:214. World Health Organization Classification of Tumours; vol Coupland SE, Foss HD, Assaf C, et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology. 1999; 106(11): Woog JJ, Kim YD, Yeatts RP, et al. Natural Killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006;113(1): Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin s Disease Staging Classification. Cancer Res. 1971; 31(11): Musshoff K. Clinical staging classification of non-hodgkin s lymphomas [in German]. Strahlentherapie. 1977;153(4): Ruskoné-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon AC, de Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003; 52(6): Gardiner JA, White VA, Gascoyne RD, Rootman J. Histopathologic, immunophenotypic and genotypic analyses in ocular adnexal lymphoproliferative disorders. Aust N Z J Ophthalmol. 1992;20(3): Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31(2): Hatef E, Roberts D, McLaughlin P, Pro B, Esmaeli B. Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma. Arch Ophthalmol. 2007;125(12): Plaisier MB, Sie-Go DM, Berendschot TT, Petersen EJ, Mourits MP. Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome. Orbit. 2007;26(2): Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to Hum Pathol. 1990;21(9): Johnson TE, Tse DT, Byrne GE Jr, et al. Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthal Plast Reconstr Surg. 1999;15(3): Shields CL, Shields JA, Carvalho C, Rundle P, Smith AF. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology. 2001;108(5): Wanyura H, Uliasz M, Kaminski A, Samolczyk-Wanyura D, Smolarz-Wojnowska A. Diagnostic difficulties and treatment of non-hodgkin lymphoma of the orbit. J Craniomaxillofac Surg. 2007;35(1): Martinet S, Ozsahin M, Belkacémi Y, et al. Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55(4): Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113(12): Roe RH, Finger PT, Kurli M, Tena LB, Iacob CE. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma. Ophthalmology. 2006;113(10): Meunier J, Rouic L, Dendale R, et al. Conjunctival low-grade non-hodgkin s lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leuk Lymphoma. 2006;47(7): Coupland SE, White V, Rootman J, et al. TNM Staging of Ocular Adnexal Lymphomas. In: Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al
6 28. Sigelman J, Jakobiec FA. Lymphoid lesions of the conjunctiva: relation of histopathology to clinical outcome. Ophthalmology. 1978;85(8): Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA. Mantle cell lymphoma in the ocular adnexal region. Ophthalmology. 2005; 112(1): Coupland SE, Hummel M, Stein H. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol. 2002;47(5): Medeiros LJ, Harris NL. Lymphoid infiltrates of the orbit and conjunctiva: a morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol. 1989; 13(6): Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Gräff A, Buchen R, Witschel H. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol. 2001;85(1): McKelvie PA, McNab A, Francis IC, Fox R, O Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol. 2001; 29(6): Sharara N, Holden JT, Wojno TH, Feinberg AS, Grossniklaus HE. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology. 2003;110(6): Charlotte F, Doghmi K, Cassoux N, et al. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases. Virchows Arch. 2006;448(4): Ness GO, Lybæk H, Arnes J, Rødahl E. Chromosomal imbalances in lymphoid tumors of the orbit. Invest Ophthalmol Vis Sci. 2002;43(1): Matteucci C, Galieni P, Leoncini L, et al. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol. 2003;200(5): Tanimoto K, Sekiguchi N, Yokota Y, et al. Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma. BMC Cancer. 2006; 6: Ruiz A, Reischl U, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol. 2007;31(5): Kim WS, Honma K, Karnan S, et al. Genome-wide array-based comparative genomic hybridization of ocular marginal zone b cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer. 2007;46(8): Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosomal band 6q23.3 q.24.1 loss in ocular adnexal marginal zone B-cell lymphoma. Genes Chromosomes Cancer. 2008;47(1):1 7. Arch Pathol Lab Med Vol 133, August 2009 TNM Staging for OAL Coupland et al 1267
Conjunctival CD5+ MALT lymphoma and review of literatures
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Conjunctival CD5+ MALT lymphoma and review of literatures M Fard Citation M Fard. Conjunctival CD5+ MALT lymphoma and review of literatures.
More informationProtocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Ocular Adnexa
Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Ocular Adnexa Protocol applies to primary hematopoietic neoplasms of the conjunctiva, orbital soft tissue, lacrimal
More informationLong term outcome of ocular adnexal lymphoma subtyped according to the REAL classification
Br J Ophthalmol 2001;85:63 69 63 University Eye Hospital, Freiburg, Germany C Auw-Haedrich A Kapp R Buchen H Witschel Department of Pathology, UKBF, Berlin, Germany S E Coupland Department of Pathology,
More information6 th Reprint Handbook Pages AJCC 7 th Edition
6 th Reprint Handbook Pages AJCC 7 th Edition AJCC 7 th Edition Errata for 6 th Reprint Table 1 Handbook No Significant Staging Clarifications for 6 th Reprint AJCC 7 th Edition Errata for 6 th Reprint
More informationcategory cm0. Category will ensure it T1 melanoma. 68 Retinoblastoma
AJCC 8 th Edition Chapter 1 Principles of Cancer Staging: Node Status Not Required in Rare Circumstances Clinical Staging, cn Category For some cancer sites in which lymph node involvement is rare, patients
More informationOcular Adnexal MALTomas: Case Series of Patients Treated With Primary Radiation
Ocular Adnexal MALTomas: Case Series of Patients Treated With Primary Radiation Wesley Russell, MD, Arnold Herskovic, MD, David Gessert, Jack A. Cohen, MD, Jonathan B. Rubenstein, MD, and Stephanie A.
More informationProtocol for the Examination of Specimens From Patients With Hodgkin Lymphoma*
Protocol for the Examination of Specimens From Patients With Hodgkin Lymphoma* Version: Hodgkin 3.1.0.1 Protocol Posting Date: October 2013 This protocol is NOT required for accreditation purposes *This
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationDuring past decades, because of the lack of knowledge
Staging and Classification of Lymphoma Ping Lu, MD In 2004, new cases of non-hodgkin s in the United States were estimated at 54,370, representing 4% of all cancers and resulting 4% of all cancer deaths,
More informationCarcinoma of the Renal Pelvis and Ureter Histopathology
Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family
More informationS1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES
Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Indigenous
More informationOcular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells
JCP Online First, published on October 27, 2010 as 10.1136/jcp.2010.082156 1 Department of Ophthalmology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan 2 Department of Pathology,
More informationCODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser
CODING STAGE: TNM AND OTHER STAGING SYSTEMS Liesbet Van Eycken Otto Visser OVERVIEW PART I Introduction What is stage? Why stage? History and publications of TNM Classification Clinical and pathologic
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationFOLLICULARITY in LYMPHOMA
FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular
More informationMantle Cell Lymphoma Diagnosed by Conjunctival Salmon-Pink Lesion Biopsy
Case Study J Clin Exp Hematop Vol. 54, No. 2, Oct. 2014 Mantle Cell Lymphoma Diagnosed by Conjunctival Salmon-Pink Lesion Biopsy Toshihiko Matsuo, 1) Kouichi Ichimura, 2) and Shiro Kubonishi 3) Conjunctival
More informationAJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center
AJCC Cancer Staging 8 th Edition Prostate Chapter 58 Judd W Moul, MD, FACS Executive Committee, AJCC Professor and Director, Duke Prostate Center Duke University Durham, North Carolina Validating science.
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationCarcinoma of the Urinary Bladder Histopathology
Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family
More informationPrimary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type
Primary Cutaneous Melanoma Pathology Reporting Proforma Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth DD MM YYYY Sex Male Female
More informationGastric Cancer Histopathology Reporting Proforma
Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate
More information6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationImmunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation
Immunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation Toshinobu Kubota, Yasushi Yatabe, Shinobu Awaya, Junpei Asai and Naoyoshi Mori Department of Ophthalmology and Pathology,
More informationDescriptor Definition Author s notes TNM descriptors Required only if applicable; select all that apply multiple foci of invasive carcinoma
S5.01 The tumour stage and stage grouping must be recorded to the extent possible, based on the AJCC Cancer Staging Manual (7 th Edition). 11 (See Tables S5.01a and S5.01b below.) Table S5.01a AJCC breast
More informationThyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES
AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been
More information3/23/2017. Disclaimer. Common Changes in TNM Staging. Overview. Overview. Understanding Terminology. Overview
Common Changes in TNM Staging Understanding the General Rules of Cancer Staging Thomas P. Baker, MD FCAP March 5, 2017 Disclaimer The identification of specific products or scientific instrumentation is
More informationThe Clinical Characteristics and Treatment Results of Ocular Adnexal Lymphoma
The Clinical Characteristics and Treatment Results of Ocular Adnexal Lymphoma Jung-Min Woo, MD 1, Chien-Kue Tang, MD 1, Mee-Sook Rho, MD 2, Jin-Hwa Lee, MD 3, Hyuk-Chan Kwon, MD 4, Hee-Bae Ahn, MD 1 Department
More informationProtocol for the Examination of Specimens From Patients With Hodgkin Lymphoma
Protocol for the Examination of Specimens From Patients With Hodgkin Lymphoma Protocol applies to Hodgkin lymphoma involving any site. # Based on AJCC/UICC TNM, 7 th Edition Protocol web posting date:
More informationOcular Adnexal Lymphomas: An Eye Care Service Experience in Turkey
Original Article Ocular Adnexal Lymphomas: An Eye Care Service Experience in Turkey B Kiziltas, C Baskan, R Duman 1, MS Dal 1 Department of Ophthalmology, Ankara Oncology Hospital, Ankara, 1 Department
More informationMantle Cell Lymphoma in the Orbital and Adnexal Region
Mantle Cell Lymphoma in the Orbital and Adnexal Region Peter Rasmussen, Lene Dissing Sjö, Jan Ulrik Prause, Elisabeth Ralfkiaer, Steffen Heegaard To cite this version: Peter Rasmussen, Lene Dissing Sjö,
More informationMittal S et al. OncoExpert, 2016, Vol. 2(1): ISSN:
OncoExpert (2016), Vol. 2, Issue 1 Review Article Received on 05 May, 2015; Received in revised form 18 October, 2015; Accepted on 14 December, 2015 PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA OF BONE: MANAGING
More informationOrbital Tumors - A Clinico Pathological Study
Orbital Tumors - A Clinico Pathological Study Radha. J. DO, Ani Sreedhar. MS. Little Flower Hospital, Angamaly, Kerala ORIGINAL ARTICLES Abstract: Aim. To study the clinical and histopathological profiles
More informationLimited Role of Bone Marrow Aspiration and Biopsy in the Initial Staging Work-up of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in Korea
Gut and Liver, Vol. 8, No. 6, November 2014, pp. 637-642 ORiginal Article Limited Role of Bone Marrow Aspiration and Biopsy in the Initial Staging Work-up of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
More informationACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA
ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA ACHIEVING EXCELLENCE IN ABSTRACTING LYMPHOMA Recoding Audit Performed in 2009 260 cases audited 17 data items audited per case 4420 possible discrepancies
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationI have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.
Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationTumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma
Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given
More informationThe many faces of extranodal lymphoma
The many faces of extranodal lymphoma Frank Pameijer Departments of Radiology and Radiation Oncology University Medical Center Utrecht Special thanks to Ilona M Schmalfuss, MD University of Florida Gainesville,
More informationOriginal Articles Primary orbital melanoma in association with cellular blue nevus
Original Articles Primary orbital melanoma in association with cellular blue nevus Tarek El-Sawy, MD, PhD, a Mathieu F. Bakhoum, PhD, a Michael Tetzlaff, MD, PhD, b Qasiem J. Nasser, MD, a Victor G. Prieto,
More informationFINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
More informationBCR-ABL1 positive Myeloid Sarcoma Nicola Austin
BCR-ABL1 positive Myeloid Sarcoma Nicola Austin Cytocell UK & Ireland User Group Meeting Jesus College, Cambridge 4 th - 5 th April 2017 Myeloid Sarcoma WHO Classification Tumours of Haematopoietic and
More informationCase Report Mantle Cell Lymphoma and Involvement of the Orbit and Ocular Adnexa
Case Reports in Pathology Volume 2013, Article ID 581856, 6 pages http://dx.doi.org/10.1155/2013/581856 Case Report Mantle Cell Lymphoma and Involvement of the Orbit and Ocular Adnexa Elham Vali Khojeini,
More information14. Mucosal Melanoma of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationSurveillance following treatment of primary ocular melanoma
Surveillance following treatment of primary ocular melanoma Introduction 50% of UM patients relapse with predominantly liver metastases Risk of metastatic disease can be predicted relatively accurately
More informationTreatment of oligometastatic NSCLC
Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic
More informationCollaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]
CS Tumor Size Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is the physician's
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationIMRT for Orbital Maltoma: A Case Report And Review Of The Literature
IMRT for Orbital Maltoma: A Case Report And Review Of The Literature Author s Details: (1) *Kanyilmaz Gul- Author 1 organization: Conception and design, administrrative support, provision of study materials
More informationPhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA
PhenoPath Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA C urrent diagnosis of B cell non-hodgkin lymphoma (B-NHL) is based on the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid
More informationHead & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i
Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &
More informationDiagnosis and Treatment of Orbital Malignant Lymphoma: A 14-Year Review at Yamagata University
Diagnosis and Treatment of Orbital Malignant Lymphoma: A 14-Year Review at Yamagata University Hiroshi Takamura, Kazuhito Terashima and Hidetoshi Yamashita Department of Ophthalmology, Yamagata University
More informationS1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles
Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male
More informationRESEARCH ARTICLE. Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran
RESEARCH ARTICLE Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran Fahimeh Asadi-Amoli 1, Zohreh Nozarian 1 *, Hirbod Nasiri Bonaki 2, Vahid
More informationA Unique Case of Nasal NK/T Cell Lymphoma with Frequent Remission and Relapse Showing Different Histological Features During 12 Years of Follow Up
J Clin Exp Hematopathol Vol. 50, No. 1, May 2010 Case Study A Unique Case of Nasal NK/T Cell Lymphoma with Frequent Remission and Relapse Showing Different Histological Features During 12 Years of Follow
More informationSTAGE CATEGORY DEFINITIONS
CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX Tis Tis (DCIS) Tis (LCIS) Tis (Paget s) T1 T1mi T1a T1b T1c a b c
More informationThe International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements
Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.
More informationGet The Cancer Staging Manual Pdf Thyroid
Get The Cancer Staging Manual Pdf Thyroid Most people with thyroid cancer have no known risk factors that they can change, Manual. They are based on the stage of the cancer when the person is first. Staging
More informationCase Report Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission after Eradication of Helicobacter Pylori Infection
Case Reports in Gastrointestinal Medicine Volume 2011, Article ID 945752, 4 pages doi:10.1155/2011/945752 Case Report Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission
More informationLymphoma. Types of Lymphoma. Clinical signs
Lymphoma Lymphoma is a tumour originating from lymphoid tissue, either nodal (lymph ) or extranodal (thymus, spleen, mucosa, conjunctiva, or skin-associated lymphoid tissue). It is one of the most common
More informationRegression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori
Gut and Liver, Vol. 6, No. 2, April 2012, pp. 270-274 CASE REPORT Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori Soo-Kyung Park, Hwoon-Yong Jung, Do Hoon Kim,
More information10. HPV-Mediated (p16+) Oropharyngeal Cancer
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationM ALIGNANT MELANOMA OF THE UVEA STAGING FORM
CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX T0 a a a d b c d a TUMOR SIZE: S TAGE C ATEGORY D EFINITIONS LATERALITY:
More informationUSCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest
USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology
More informationLearn more about diffuse large B-cell lymphoma (DLBCL), the most common aggressive form of B-cell non-hodgkin s lymphoma 1
Learn more about diffuse large B-cell lymphoma (DLBCL), the most common aggressive form of B-cell non-hodgkin s lymphoma 1 Expression of B-cell surface antigens drives several non-hodgkin s lymphomas (NHLs)
More informationHigh risk stage II colon cancer
High risk stage II colon cancer Joel Gingerich, MD, FRCPC Assistant Professor Medical Oncologist University of Manitoba CancerCare Manitoba Disclaimer No conflict of interests 16 October 2010 Overview
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationAJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-
TX: primary tumor cannot be assessed T0: no evidence of primary tumor Tis: carcinoma in situ. T1: tumor is 2 cm or smaller AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- T2:
More informationLymphoproliferative disease of the orbit is the commonest
REVIEW ARTICLE Emmy Y. Li, MPH, FRCS, FCOphthHK,*Þ Hunter K. Yuen, MRCS, FCOphthHK,*Þ and Wah Cheuk, FHKCPath*þ Abstract: Lymphoproliferative diseases of the orbit account for majority of orbital tumors.
More informationClinical analysis of 29 cases of nasal mucosal malignant melanoma
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
More informationA CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey
A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck
More informationNon-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract.
Non-Hodgkin Lymphoma Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract. Protocol revision date: January 2005 No AJCC/UICC staging system Procedures Cytology
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationCD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting
Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja
More informationConjunctival Follicular Lymphoma after Treatment for Invasive Squamous Cell Carcinoma
Published online: December 10, 2014 1663 2699/14/0053 0444$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3.0 Unported license (CC BY-NC)
More informationCLINICAL SCIENCES. for less than 1% of all malignant eyelid lesions. 1-4 In a survey of
CLINICAL SCIENCES Metastatic Tumors to the Eyelid Report of 20 Cases and Review of the Literature Carlos ianciotto, MD; Hakan Demirci, MD; Carol L. Shields, MD; Ralph C. Eagle Jr, MD; Jerry A. Shields,
More informationRadiation Therapy for Extranodal Lymphomas
Radiation Therapy for Extranodal Lymphomas Keisuke Sasai Masahiko Oguchi Editors Radiation Therapy for Extranodal Lymphomas Editors Keisuke Sasai Department of Radiation Oncology Juntendo University Faculty
More informationPRIMARY GASTRIC LYMPHOMA: CASE REPORT WITH REVIEW OF LITERATURE
PRIMARY GASTRIC LYMPHOMA: CASE REPORT WITH REVIEW OF LITERATURE Rana K. Sherwani, *Kafil Akhtar, Noorin Zaidi, Anjum Ara Department of Pathology, J.N. Medical College, Aligarh Muslim University, Aligarh,
More informationMarginal zone lymphoma: Associated autoimmunity & auto-immune disorders
Marginal zone lymphoma: Associated autoimmunity & auto-immune disorders Dr Andrew Wotherspoon Histopathology department Royal Marsden Hospital London, UK AI disorders affect 5-9% of the world populagon
More information8th Edition of the TNM Classification for Lung Cancer. Proposed by the IASLC
8th Edition of the TNM Classification for Lung Cancer Proposed by the IASLC Introduction Stage classification - provides consistency in nomenclature - improves understanding of anatomic extent of tumour
More informationStaging for Residents, Nurses, and Multidisciplinary Health Care Team
Staging for Residents, Nurses, and Multidisciplinary Health Care Team Donna M. Gress, RHIT, CTR Validating science. Improving patient care. Learning Objectives Introduce the concept and history of stage
More informationThe 8th Edition Lung Cancer Stage Classification
The 8th Edition Lung Cancer Stage Classification Elwyn Cabebe, M.D. Medical Oncology, Hematology, and Hospice and Palliative Care Valley Medical Oncology Consultants Director of Quality, Medical Oncology
More informationOriginal article. Ken-ichi Mafune 1, Yoichi Tanaka 1, Yasuo Suda 1, and Toshiyuki Izumo 2. Introduction
Gastric Cancer (2001) 4: 137 143 Original article 2001 by International and Japanese Gastric Cancer Associations Outcome of patients with non-hodgkin s lymphoma of the stomach after gastrectomy: clinicopathologic
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationClinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome to Cutaneous Melanoma
ISRN Dermatology Volume 2013, Article ID 586915, 5 pages http://dx.doi.org/10.1155/2013/586915 Clinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome
More informationNasreen A. Syed, MD F.C. Blodi Eye Pathology Laboratory University of Iowa
Nasreen A. Syed, MD F.C. Blodi Eye Pathology Laboratory University of Iowa No financial disclosures No discussion of off-label use of medications or unapproved devices 67 year old male referred to Oculoplastics
More informationPhysician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters
Physician to Physician Head and Neck William M. Lydiatt, MD Chair of Surgery Nebraska Methodist Hospital Clinical Professor of Surgery, Creighton University Validating science. Improving patient care.
More informationNasal Cavity CS Tumor Size (Revised: 02/03/2010)
Nasal Cavity C30.0 C30.0 Nasal cavity (excludes nose, NOS C76.0) Note: Laterality must be coded for this site, except subsites Nasal cartilage and Nasal septum, for which laterality is coded 0. CS Tumor
More informationL ARYNX S TAGING F ORM
CLI N I CA L Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX T0 Tis a b L ARYNX S TAGING F ORM LATERALITY: TUMOR SIZE: left
More informationOcular adnexal lymphoma comparison of MALT lymphoma with other histological types
742 The Research Foundation, The Royal Victoria Eye and Ear Hospital, Dublin 2, Ireland M Cahill P Moriarty The National Ophthalmic Pathology Laboratory, The Royal Victoria Eye and Ear Hospital, Dublin
More informationLymphoma Read with the experts
Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize
More informationStage: The Language of Cancer
Stage: The Language of Cancer American Joint Committee on Cancer American College of Surgeons Chicago, IL Validating science. Improving patient care. No materials in this presentation may be repurposed
More informationPolicy for Central Nervous System [CNS] Prophylaxis in Lymphoid Malignancies
Policy for Central Nervous System [CNS] Prophylaxis in Lymphoid Malignancies UNCONTROLLED WHEN PRINTED Note: NOSCAN Haematology MCN has approved the information contained within this document to guide
More informationLymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients
Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,
More informationGUIDELINES ON PROSTATE CANCER
10 G. Aus (chairman), C. Abbou, M. Bolla, A. Heidenreich, H-P. Schmid, H. van Poppel, J. Wolff, F. Zattoni Eur Urol 2001;40:97-101 Introduction Cancer of the prostate is now recognized as one of the principal
More information[A RESEARCH COORDINATOR S GUIDE]
2013 COLORECTAL SURGERY GROUP Dr. Carl J. Brown Dr. Ahmer A. Karimuddin Dr. P. Terry Phang Dr. Manoj J. Raval Authored by Jennifer Lee A cartoon about colonoscopies. 1 [A RESEARCH COORDINATOR S GUIDE]
More informationFrequency and Pattern of Bone Marrow Infiltration in Non- Hodgkin s Lymphoma
Original Article Frequency and Pattern of Bone Marrow Infiltration in Non- Hodgkin s Lymphoma Ayaz Lone, 1 Samina Naeem 2 Abstract Introduction: Lymphomas are divided into two, groups Hodgkin s Lymphoma
More informationHead & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging
AJCC 8 th Edition Staging Head & Neck Staging Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More information